NCT05134493

Brief Summary

About 20% of strokes are caused by emboli deriving from a carotid plaque. In symptomatic patients with carotid stenosis grater than 70% the Carotid Endarterectomy (CEA) reduces stroke risk by about 75% and is generally accepted as being cost effective. However also in these cases there is a part of the population that, according to the morphological plaque characteristics, could better benefit from a conservative medical treatment. Improving the Best Medical Treatment, the situation seems to be even less clear in asymptomatic patients, where probably it would need to treat at least 32 patients in order to prevent one single ictus. Different parameters have been considered in order to determine, among the asymptomatic patients the ones that more than others could benefit from a surgical revascularisation instead of a medical treatment. Between these parameters, the quality of the plaque (vulnerability) and the micro-embolic signals (MES) detection with the Transcranial Doppler (TCD) Holter seems to be the most relevant. Another interesting aspect is trying to establish whether plaques can determine a different embolic risk in relation to the different histological findings. Therefore, it seems interesting and reasonable trying to establish a correlation between these two parameters in asymptomatic patients as in the symptomatic ones in order to make more and more appropriate a surgical plaque removal according to the specific risk of each patient in a set of tailored surgery. It consists in a descriptive observational study, since it intends to describe the embolic signals detection (MES) counted in automatic way with the TCD Holter, in patients affected by carotid stenosis, before and after the surgical operation. In particular it consists in a monocentric, longitudinal, prospective cohort study since it intends to analyse a group of patients (already candidates to CEA) that experiences a specific event (MES) before and after the surgical plaque removal, in a precise span of time. Since the treatment, removing the plaque, should remove the embolic focus too, a significant reduction of microembolic signals in post-operative time is expected. This reduction has been esteemed around about the 70% among candidates to CEA. Patients taken on responsibility of the equipe will undergo an ultrasonographic investigation for the carotid stenosis, histological characterization of the plaque based on the Gray-Weale classification and TCD-Holter for MES.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 27, 2018

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

June 25, 2021

Completed
5 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
5 months until next milestone

First Posted

Study publicly available on registry

November 26, 2021

Completed
Last Updated

November 26, 2021

Status Verified

November 1, 2021

Enrollment Period

3 years

First QC Date

June 25, 2021

Last Update Submit

November 14, 2021

Conditions

Keywords

carotidcarotid stenosisplaquestroke risktranscranial dopplerTCDhistology

Outcome Measures

Primary Outcomes (3)

  • MES COUNT

    number of MES

    before surgery

  • MES COUNT

    number of MES

    24 hours after surgery

  • MES COUNT

    number of MES

    after 30 days from the surgery

Secondary Outcomes (1)

  • RISK RATE

    through study completion, an average of 60 days

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

We selected patients already got in touch with the hospital, already put in list for a carotid surgical revascularization.

You may qualify if:

  • Informed consent signed
  • Age\>18y.o.
  • Carotid stenosis \>70% and/or vulnerable plaque

You may not qualify if:

  • Inability to give the informed consent
  • Age\<18y.o.
  • Carotid stenosis \< 70 %
  • Patients already treated with CEA in the same seat
  • Impossibility to find the insonation window
  • Patients not in best medical treatment therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

OCB Baggiovara, AOU Modena

Modena, 41126, Italy

Location

Related Publications (1)

  • Pizzarelli G, Gennai S, Leone N, Covic T, Moratto R, Silingardi R. Transcranial Doppler detects micro emboli in patients with asymptomatic carotid stenoses undergoing endarterectomy. J Vasc Surg. 2023 Mar;77(3):811-817.e2. doi: 10.1016/j.jvs.2022.10.003. Epub 2022 Oct 13.

Biospecimen

Retention: SAMPLES WITHOUT DNA

carotid plaque

MeSH Terms

Conditions

Carotid StenosisCarotid Artery DiseasesStrokePlaque, Amyloid

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Roberto Moratto, Dr

    AOU Modena e Reggio Emilia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Ginevra Pizzarelli, Medico in Formazione Specialistica

Study Record Dates

First Submitted

June 25, 2021

First Posted

November 26, 2021

Study Start

June 27, 2018

Primary Completion

June 30, 2021

Study Completion

June 30, 2021

Last Updated

November 26, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations